PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8564679

[Midazolam versus placebo before spinal anesthesia].

D Fletcher·K Samii·A Bénichou·D Fillette·A Bertin·M Germond·D Laverdisse·J M Mascaro·E Normand·Y Piroelle
View original source ↗Export metadata ↓

Abstract

The goal of this randomized, double blind and multicentric study was to compare the effects of midazolam (M) and placebo (P) administered by titration before puncture for spinal anaesthesia on the comfort of 211 patients scheduled for elective surgery after oral premedication with hydroxyzine. The administered dose of midazolam was 3.4 +/- 1.3 mg (mean +/- SD). Anxiety was nil in 92% of the patients of the M group and in 64% of the patients of the P group (p < 0.001) and memorization of the pain of the puncture was reported in 34% of the patients of the M group and in 66% of the patients of the P group (p < 0.001). However cooperation of the patient and easiness of the puncture were similar in both groups. In conclusion titrated sedation with midazolam before puncture for spinal anaesthesia increases the comfort of the patient.

Explore related subjects

Adjuvants, AnesthesiaAdultAgedAnesthesia, SpinalAnxietyFemaleHumansHypnotics and SedativesMaleMidazolamMiddle AgedPlacebosClinical TrialEnglish AbstractJournal ArticleMulticenter StudyRandomized Controlled Trial

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D Fletcher, K Samii, A Bénichou, D Fillette, A Bertin, M Germond, D Laverdisse, J M Mascaro, E Normand, Y Piroelle. 1995. [Midazolam versus placebo before spinal anesthesia].. https://pubmed.ncbi.nlm.nih.gov/8564679/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1999

Medium-frequency oscillations dominate the inspiratory nerve discharge of anesthetized newborn rats.

In this study we examined the synchronization of the discharge of phrenic and recurrent laryngeal motoneurons in anesthetized rat pups 14 to 36 days of age and kittens, 14-15 days old. We found that the inspiratory nerve activity consisted of synchronized bursts separated by 20-35 ms, corresponding to medium-frequency oscillations (MFO). Accordingly, the autospectra of the neurograms had two peaks, one at the respiratory rate and the other between 22. 8-43.0 Hz. No significant coherence was found between MFOs in the discharges of different nerves. High-frequency oscillations (HFO) characteristic for the adult inspiratory nerve activity were not present in the newborn rats. These findings demonstrate that phrenic nerve discharge of rat pups, like that of kittens and piglets, is in the MFO range, and suggest that MFO activity is an index of an early developmental stage of the respiratory system.

Adjuvants, Anesthesia↗
PubMed1999

The safety and effectiveness of remifentanil as an adjunct sedative for regional anesthesia.

UNLABELLED: We assessed the sedative potential of continuous infusions of remifentanil with a validated composite alertness scale in 160 patients (ASA physical status I or II) undergoing hip replacement surgery with spinal block (n = 61) or hand surgery using brachial plexus block (n = 93). They were randomized to receive one of the following initial dose regimens in double-blinded fashion: placebo or 0.04, 0.07, or 0.1 microg x kg(-1) x min(-1) remifentanil subsequently titrated to effect. Additional midazolam IV was allowed for adequate sedation as required. The combined analysis of both surgery groups revealed a dose-related increase in achievement of sedation level > or =2 within 15 min of the start of the study drug infusion; all remifentanil dose comparisons with placebo reached significance (P < 0.001). The remifentanil 50% effective dose for a composite sedation level > or =2 within 15 min of the start of drug infusion was estimated as 0.043 microg x kg(-1) x min(-1) (95% confidence interval 0.01, 0.059). The requirement for midazolam decreased with increasing remifentanil dose compared with placebo (P < 0.001). The median time to return to alertness after the end of infusion was 10-12 min in the remifentanil groups and 5 min in the placebo group. Significant incidences of nausea, pruritus, sweating, and respiratory depression were reported during remifentanil infusions compared with placebo. The data suggest that remifentanil may be useful for supplementation of regional anesthesia, provided that ventilation is carefully monitored. IMPLICATIONS: In this dose-finding, placebo-controlled study, remifentanil infusions were used to provide sedation during spinal and brachial plexus regional anesthesia. The 50% effective dose for achievement of sedation was 0.043 microg x kg(-1) x min(-1). Return to alertness occurred after 10-12 min (median time). Remifentanil infusions can be used to supplement regional anesthesia, but this requires careful monitoring of ventilation.

Adjuvants, Anesthesia↗
PubMed1999

Effects of intravenously administered glycopyrrolate in anesthetized horses.

The purpose of this study was to determine the heart rate (HR) and blood pressure (BP) effect of glycopyrrolate in anesthetized horses with low HR (< or = 30 beats/min). The horses were randomly treated with glycopyrrolate (2.5 micrograms/kg body weight (BW)) or saline, intravenously (i.v.) (n = 17). If HR failed to increase (by > 5 beats/min within 10 min), glycopyrrolate (same dose) was administered. Heart rate increased by > 5 beats/min in 3 out of 9 horses following the initial glycopyrrolate treatment. Overall changes in HR and mean BP were not significantly different, while systolic and diastolic BP increased significantly (P < 0.025 using a Bonferroni corrected paired t-test). On the 2nd treatment, 3 out of 7 horses given 2.5 micrograms/kg BW glycopyrrolate, and 4 out of 5 horses given 5.0 micrograms/kg BW (total dose) showed an increase in heart rate of > 5 beats/min, which was significant. A significant increase in BP was produced following treatment with 2.5 micrograms/kg BW, but not following 5.0 micrograms/kg BW. A final increase in HR, of > 5 beats/min, was associated with a significant rise in BP (P < 0.05 using an unpaired t-test). In conclusion, an increase in HR can occur with 2.5 to 5.0 micrograms of glycopyrrolate/kg BW, i.v., and results in improvement in BP in anesthetized horses.

Adjuvants, Anesthesia↗